| Primary |
| Hypertension |
25.0% |
| Steroid Therapy |
18.8% |
| Renal Failure Chronic |
12.5% |
| Contusion |
6.3% |
| Diabetic Nephropathy |
6.3% |
| Dyslipidaemia |
6.3% |
| Hyperuricaemia |
6.3% |
| Musculoskeletal Stiffness |
6.3% |
| Proteinuria |
6.3% |
| Pyrexia |
6.3% |
|
| Dyskinesia |
20.0% |
| Pneumonia Aspiration |
20.0% |
| Sluggishness |
20.0% |
| Toxic Epidermal Necrolysis |
20.0% |
| Ultrasound Liver Abnormal |
20.0% |
|
| Secondary |
| Hypertension |
27.6% |
| Rheumatoid Arthritis |
9.2% |
| Product Used For Unknown Indication |
8.1% |
| Drug Use For Unknown Indication |
6.3% |
| Pneumonia |
5.5% |
| Acute Myocardial Infarction |
5.1% |
| Diabetes Mellitus |
5.1% |
| Chronic Obstructive Pulmonary Disease |
4.4% |
| Pyrexia |
4.0% |
| Myocardial Infarction |
3.3% |
| Angina Pectoris |
2.9% |
| Asthma |
2.6% |
| Chronic Hepatitis C |
2.6% |
| Gastritis |
2.6% |
| Cardiac Failure |
2.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
| Cardiovascular Disorder |
1.8% |
| Diabetic Nephropathy |
1.5% |
| Folate Deficiency |
1.5% |
| Hyperlipidaemia |
1.5% |
|
| Hypoglycaemia |
15.0% |
| Toxic Skin Eruption |
13.3% |
| Toxic Epidermal Necrolysis |
8.3% |
| Oedema |
6.7% |
| Convulsion |
5.0% |
| Rash |
5.0% |
| Sepsis |
5.0% |
| Wheezing |
5.0% |
| Jaundice Cholestatic |
3.3% |
| Platelet Count Increased |
3.3% |
| Pruritus |
3.3% |
| Renal Failure Acute |
3.3% |
| Rhabdomyolysis |
3.3% |
| Status Asthmaticus |
3.3% |
| Stevens-johnson Syndrome |
3.3% |
| Surfactant Protein Increased |
3.3% |
| Thrombocytopenia |
3.3% |
| Thrombosis In Device |
3.3% |
| Acute Myocardial Infarction |
1.7% |
| Altered State Of Consciousness |
1.7% |
|
| Concomitant |
| Hypertension |
29.3% |
| Rheumatoid Arthritis |
9.7% |
| Product Used For Unknown Indication |
6.8% |
| Prophylaxis |
6.3% |
| Drug Use For Unknown Indication |
5.6% |
| Diabetes Mellitus |
4.6% |
| Angina Pectoris |
3.8% |
| Osteoporosis |
3.6% |
| Hyperlipidaemia |
3.3% |
| Acute Myocardial Infarction |
3.1% |
| Chronic Hepatitis C |
3.1% |
| Gastritis |
2.9% |
| Constipation |
2.5% |
| Cardiac Failure |
2.5% |
| Myocardial Infarction |
2.4% |
| Type 2 Diabetes Mellitus |
2.2% |
| Cerebral Infarction |
2.2% |
| Insomnia |
2.1% |
| Herpes Zoster |
2.0% |
| Infection Prophylaxis |
1.9% |
|
| Vomiting |
10.7% |
| White Blood Cell Count Decreased |
9.0% |
| Interstitial Lung Disease |
8.4% |
| Pneumonia |
7.0% |
| Rash |
6.7% |
| Renal Impairment |
6.7% |
| Hepatic Function Abnormal |
5.5% |
| Renal Failure |
5.5% |
| Hypoglycaemia |
4.3% |
| Rhabdomyolysis |
4.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.8% |
| Cardiac Failure |
3.5% |
| Pyrexia |
3.5% |
| Renal Disorder |
3.5% |
| Renal Failure Acute |
3.5% |
| Platelet Count Decreased |
3.2% |
| Respiratory Failure |
2.9% |
| Tremor |
2.9% |
| Cerebral Infarction |
2.6% |
| Malignant Neoplasm Progression |
2.6% |
|
